Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Differences in egg and milk food challenge outcomes based on tolerance to the baked form.

Capucilli P, Cianferoni A, Fiedler J, Gober L, Pawlowski N, Ram G, Saltzman R, Spergel JM, Heimall J.

Ann Allergy Asthma Immunol. 2018 Jul 21. pii: S1081-1206(18)30581-7. doi: 10.1016/j.anai.2018.07.018. [Epub ahead of print]

PMID:
30036581
2.

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Da Fonseca M, Golpanian S, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Green G, Oliva AA, Hare JM.

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1513-1522. doi: 10.1093/gerona/glx137.

3.

Invariant natural killer cells change after an oral allergy desensitization protocol for cow's milk.

Cianferoni A, Saltzman R, Saretta F, Barni S, Dudek E, Kelleher M, Spergel JM.

Clin Exp Allergy. 2017 Nov;47(11):1390-1397. doi: 10.1111/cea.12975. Epub 2017 Aug 23.

PMID:
28685970
4.

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.

Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM.

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1505-1512. doi: 10.1093/gerona/glx056.

5.

Using Simulation to Model Improvements in Pediatric Bed Placement in an Acute Care Hospital.

Lambton J, Roeder T, Saltzman R, Param L, Fernandes R.

J Nurs Adm. 2017 Feb;47(2):88-93. doi: 10.1097/NNA.0000000000000445.

PMID:
28106681
6.

Evaluation and subsequent safe administration of rabies vaccine to a child presumably allergic to the gelatin content of PCECV Rabavert.

Gupta M, Sindher S, Saltzman R, Heimall J.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):281-2. doi: 10.1016/j.jaip.2014.10.005. Epub 2014 Nov 18. No abstract available.

PMID:
25609331
7.

Oral food challenge to wheat: a near-fatal anaphylaxis and review of 93 food challenges in children.

Cianferoni A, Khullar K, Saltzman R, Fiedler J, Garrett JP, Naimi DR, Spergel JM.

World Allergy Organ J. 2013 Aug 21;6(1):14. doi: 10.1186/1939-4551-6-14.

8.

Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency.

Heimall J, Keller M, Saltzman R, Bunin N, McDonald-McGinn D, Zakai E, de Villartay JP, Moshous D, Ariue B, McCarthy EA, Devlin BH, Parikh S, Buckley RH, Markert ML.

J Clin Immunol. 2012 Oct;32(5):1141-4. doi: 10.1007/s10875-012-9741-9. Epub 2012 Aug 3.

PMID:
22864628
9.

Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levels.

Karamchandani-Patel G, Hanson EP, Saltzman R, Kimball CE, Sorensen RU, Orange JS.

Ann Allergy Asthma Immunol. 2011 Jul;107(1):50-6. doi: 10.1016/j.anai.2011.03.009. Epub 2011 May 4.

10.

Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin.

Jyonouchi S, Abraham V, Orange JS, Spergel JM, Gober L, Dudek E, Saltzman R, Nichols KE, Cianferoni A.

J Allergy Clin Immunol. 2011 Jul;128(1):102-109.e13. doi: 10.1016/j.jaci.2011.02.026. Epub 2011 Apr 1.

11.

IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function.

Orange JS, Roy-Ghanta S, Mace EM, Maru S, Rak GD, Sanborn KB, Fasth A, Saltzman R, Paisley A, Monaco-Shawver L, Banerjee PP, Pandey R.

J Clin Invest. 2011 Apr;121(4):1535-48. doi: 10.1172/JCI44862. Epub 2011 Mar 7.

12.

Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.

Sarisky RT, Bacon TH, Boon RJ, Duffy KE, Esser KM, Leary J, Locke LA, Nguyen TT, Quail MR, Saltzman R.

Arch Virol. 2003 Sep;148(9):1757-69.

PMID:
14505088
13.

Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.

Sarisky RT, Bacon T, Boon R, Locke L, Nguyen TT, Leary J, Esser K, Saltzman R.

Antimicrob Agents Chemother. 2002 Sep;46(9):2848-53.

14.

Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study.

Tyring S, Engst R, Corriveau C, Robillard N, Trottier S, Van Slycken S, Crann RA, Locke LA, Saltzman R, Palestine AG; Collaborative Famciclovir Ophthalmic Zoster Research Group.

Br J Ophthalmol. 2001 May;85(5):576-81.

15.

Ankle fracture with syndesmotic injury.

Saltzman R, French BG, Mizel MS.

J Orthop Trauma. 2000 Feb;14(2):113-5. No abstract available.

PMID:
10716383
16.

Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.

Schacker T, Hu HL, Koelle DM, Zeh J, Saltzman R, Boon R, Shaughnessy M, Barnum G, Corey L.

Ann Intern Med. 1998 Jan 1;128(1):21-8.

PMID:
9424977
17.

Contempo 1997: dermatology.

Marks L, Saltzman R.

JAMA. 1997 Oct 8;278(14):1148; author reply 1149. No abstract available.

PMID:
9326466
18.
19.

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T, Boon R, Saltzman R.

Ann Intern Med. 1995 Jul 15;123(2):89-96.

PMID:
7778840
20.

Safety of famciclovir in patients with herpes zoster and genital herpes.

Saltzman R, Jurewicz R, Boon R.

Antimicrob Agents Chemother. 1994 Oct;38(10):2454-7.

Supplemental Content

Loading ...
Support Center